Interact to see
Advertisement
Advertisement
HGHRX vs JFNIX
HGHRX vs JFNIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
HGHRX vs. JFNIX commentary
Aug 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HGHRX is a Buy and JFNIX is a Buy.
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.29B vs. HGHRX (755M). JFNIX pays higher dividends than HGHRX: JFNIX (0.41) vs HGHRX (0.00). HGHRX was incepted earlier than JFNIX: HGHRX (19 years) vs JFNIX (16 years). HGHRX (1.63) is less costly to investors than JFNIX (0.77). HGHRX is a more actively managed with annual turnover of: 40.00 vs. JFNIX (35.00). HGHRX has a lower initial minimum investment than JFNIX: HGHRX (0) vs JFNIX (2500). JFNIX annual gain was more profitable for investors over the last year : -14.21 vs. HGHRX (-20.13). JFNIX return over 5 years is better than : 5.30 vs. HGHRX (-20.74).
| HGHRX | JFNIX | HGHRX / JFNIX | |
| Total Expense Ratio | 1.63 | 0.77 | 212% |
| Annual Report Gross Expense Ratio | 1.63 | 0.77 | 212% |
| Fund Existence | 19 years | 16 years | - |
| Gain YTD | -5.079 | 0.897 | -566% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 755M | 4.29B | 18% |
| Annual Yield % from dividends | 0.00 | 0.41 | - |
| Returns for 1 year | -20.13 | -14.21 | 142% |
| Returns for 3 years | -8.69 | 6.34 | -137% |
| Returns for 5 years | -20.74 | 5.30 | -391% |
| Returns for 10 years | -21.77 | 12.82 | -170% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement